Rating History for Navidea Biopharmaceuticals (NAVB) by Maxim Group

More Stocks Rated by Maxim Group | Latest Ratings for NAVB
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/18/2020 Jason McCarthy Maintain Buy
(N/A)		 3.00
(2.00)		  
 		   Details